Home
Covis Pharma

Covis Pharma Market Share Analysis for August 2026

Industry: N/A

Domaincovispharma.com

Year Founded2011

Employees201 - 500

Annual Revenue$50M - $75M

Covis Pharma

Covis Pharma (including company regionals)

covispharma.com

See more website traffic and engagement information

Covis Pharma Revenue up to August 2026 is 50M - 75M

revenue generated by Covis Pharma top domains

Covis Pharma top domains revenue over 3 years

Revenue for Covis Pharma top domains

covispharma.com50M - 75M

See more with Sales Intelligence

Total visits to Covis Pharma's top domains

Understand Covis Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

covispharma.com2.9K

See more with Sales Intelligence

Avg. visit duration in Covis Pharma's top domains

Analyze Covis Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

covispharma.com00:00:41

See more with Sales Intelligence

Avg. pageviews on Covis Pharma's top domains

See how Covis Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

covispharma.com1.97

See more with Sales Intelligence

Covis Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Covis Pharma

These are the website technologies, by industry, used by Covis Pharma top domains

Content Management System (2)

WordPress

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

Widget (2)

Popup Maker

More Technologies

5

See all

News & Signals from Covis Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCovis Pharma GmbH has revenue of $600M.He co-founded and served as CEO of Covis Pharma Group, building it into a top ten global respiratory company with more than US$600 million in annual sales and generating more than US$1.5 billion in distributed profit for shareholders.

NewsNick leaves Covis Pharma Group as SVP Supply Chain.Prior to joining Adalvo, Nick served as SVP Supply Chain at Covis Pharma and previously held senior regional and global roles at Cardinal Health, Teva Pharmaceuticals, and Johnson & Johnson.

NewsPharmaceutical Tech acquired Covis Pharma Group on Mar 14th '25.USA-based Azurity Pharmaceuticals says it has completed its acquisition of Covis Group from existing investors and the privately-held Swiss drugmaker is now a wholly-owned subsidiary of Azurity.